Tag: Dementia Drugs

Nominate a Drug for ARUK’s Dementia Drug Prioritisation Programme

Opportunities

Nominate a Drug for ARUK’s Dementia Drug Prioritisation Programme

27/09/2026 Dementia Researcher

Catchup – Salon Debate – Funding Dementia: Prevent or Treat?

Catchup – Salon Debate – Funding Dementia: Prevent or Treat?

Blog – Inequity in dementia drug development

Guest blog

Blog – Inequity in dementia drug development

05/09/2024 Dr Jodi Watt

Donanemab approved by the FDA for the Treatment of Early Symptomatic Alzheimer’s

Research News

Donanemab approved by the FDA for the Treatment of Early Symptomatic Alzheimer’s

03/07/2024 Dementia Researcher

Catch-up on the BSMS Dementia Research Conference 2023

Research News

Catch-up on the BSMS Dementia Research Conference 2023

22/05/2023 Dementia Researcher

Blog – Top Tips for Veganuary

Guest blog

Blog – Top Tips for Veganuary

04/01/2023 Dr Sam Moxon

Blog – Looking back on 2022: A year of change

Guest blog

Blog – Looking back on 2022: A year of change

09/12/2022 Dr Sam Moxon

Gantenerumab Falls Short in Phase 3

Research News

Gantenerumab Falls Short in Phase 3

15/11/2022 Alz Forum

Blog – Nanomedicine in Dementia Research

Guest blog, Tech Week

Blog – Nanomedicine in Dementia Research

08/11/2022 Dr Sam Moxon

Blog – Are We Entering a “Golden Age” of Dementia Research

Guest blog

Blog – Are We Entering a “Golden Age” of Dementia Research

12/10/2022 Dr Sam Moxon

Lecanemab Phase 3 Trial Meetings Primary Endpoint

Science

Lecanemab Phase 3 Trial Meetings Primary Endpoint

28/09/2022 Dementia Researcher

Blog – Medicines Management in Dementia

Careers, Guest blog

Blog – Medicines Management in Dementia

07/09/2022 Hannah Hussain